Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	429997	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	446227	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	446347	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	446460	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	447033	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	461866	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	471506	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	480635	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	480917	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	493614	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	517374	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	527211	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	528392	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	532336	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	540130	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	548667	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	552827	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	554783	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	554902	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	560605	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	567389	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	567905	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	575283	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	581967	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	582708	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	583087	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	585699	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	585745	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	588849	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	588975	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	602257	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	602574	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	606837	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	614737	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	620148	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	628101	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	629234	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	631012	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	636379	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	642540	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	654764	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	655297	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	656865	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	660706	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	661824	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	664587	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	668395	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	669384	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	670974	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	672437	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	674539	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	678236	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	681095	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	691498	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	694456	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	703880	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	704693	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	715180	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	717100	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	726846	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	730757	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	730858	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	734725	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	734889	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	734954	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	740113	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	743942	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	747060	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	747600	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	761079	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	764401	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	764611	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	766689	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	786869	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	787604	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	823254	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	825482	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	829432	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	836003	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	845827	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	857854	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	860297	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	861767	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	872850	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	882968	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	885048	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	893130	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	899092	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	942032	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	943097	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	974903	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	983098	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	1034957	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	1045841	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	1061791	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	1063747	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-	1339224	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+HCOO)-		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	10067	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	10645	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	10684	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	22902	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	23234	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	28431	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	31519	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	34983	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	40786	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	42213	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	42349	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	42891	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	46615	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	47845	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	49372	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	52605	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	55346	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	56242	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	56366	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	60498	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	63573	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	65870	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	67282	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	67555	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	69908	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	76623	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	78115	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	81512	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	85108	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	85434	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	86800	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	88647	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	102394	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	105722	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	106535	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	110700	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	110953	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	121943	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	126656	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	127200	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	139292	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	208018	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	259790	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	276756	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	295249	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	336981	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	367746	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	400699	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	423650	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	435348	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	473308	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+	586877	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	GAMMA-LINOLENIC ACID (CAS# 506-26-3); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y